CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 41 enrolled
Drug / intervention
Pantoprazoledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02186652
NCT02186652Phase 1Completed
CompareCT.gov

The Effect of Obesity on the Pharmacokinetics of Pantoprazole in Children and Adolescents

Phillip Brian Smith·interventional·Posted Jul 10, 2014·Updated Sep 17, 2019

In Brief

A Phase 1 clinical trial evaluating Pantoprazole for Gastroesophageal Reflux Disease. Completed, enrolled 41 participants across 4 sites.

Detailed Summary

Multicenter, comparative single-dose pharmacokinetic (PK) study

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux Disease
CountriesUnited States
CollaboratorsThe Emmes Company, LLC

Timeline

Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 10, 2014
Enrollment StartJun 4, 2014
Primary CompletionSep 13, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.0 years ago

Interventions

Pantoprazoledrug